These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 17261408)
1. Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome. Ladouceur M; Fermanian C; Lupoglazoff JM; Edouard T; Dulac Y; Acar P; Magnier S; Jondeau G Am J Cardiol; 2007 Feb; 99(3):406-9. PubMed ID: 17261408 [TBL] [Abstract][Full Text] [Related]
2. Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study. Chiu HH; Wu MH; Wang JK; Lu CW; Chiu SN; Chen CA; Lin MT; Hu FC Mayo Clin Proc; 2013 Mar; 88(3):271-6. PubMed ID: 23321647 [TBL] [Abstract][Full Text] [Related]
3. Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome. Selamet Tierney ES; Feingold B; Printz BF; Park SC; Graham D; Kleinman CS; Mahnke CB; Timchak DM; Neches WH; Gersony WM J Pediatr; 2007 Jan; 150(1):77-82. PubMed ID: 17188619 [TBL] [Abstract][Full Text] [Related]
4. Determinants of rapid progression of aortic root dilatation and complications in Marfan syndrome. Lazarevic AM; Nakatani S; Okita Y; Marinkovic J; Takeda Y; Hirooka K; Matsuo H; Kitamura S; Yamagishi M; Miyatake K Int J Cardiol; 2006 Jan; 106(2):177-82. PubMed ID: 16321689 [TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of the effect of angiotensin II receptor blocker versus β-blocker on aortic root growth in paediatric patients with Marfan syndrome. Mueller GC; Stierle L; Stark V; Steiner K; von Kodolitsch Y; Weil J; Mir TS Heart; 2014 Feb; 100(3):214-8. PubMed ID: 24270746 [TBL] [Abstract][Full Text] [Related]
7. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Groenink M; den Hartog AW; Franken R; Radonic T; de Waard V; Timmermans J; Scholte AJ; van den Berg MP; Spijkerboer AM; Marquering HA; Zwinderman AH; Mulder BJ Eur Heart J; 2013 Dec; 34(45):3491-500. PubMed ID: 23999449 [TBL] [Abstract][Full Text] [Related]
8. Nomograms for aortic root diameters in children using two-dimensional echocardiography. Gautier M; Detaint D; Fermanian C; Aegerter P; Delorme G; Arnoult F; Milleron O; Raoux F; Stheneur C; Boileau C; Vahanian A; Jondeau G Am J Cardiol; 2010 Mar; 105(6):888-94. PubMed ID: 20211339 [TBL] [Abstract][Full Text] [Related]
9. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. Ahimastos AA; Aggarwal A; D'Orsa KM; Formosa MF; White AJ; Savarirayan R; Dart AM; Kingwell BA JAMA; 2007 Oct; 298(13):1539-47. PubMed ID: 17911499 [TBL] [Abstract][Full Text] [Related]
10. [Aortic root dilatation rate in pediatric patients with Marfan syndrome treated with losartan]. Mariucci E; Guidarini M; Donti A; Lovato L; Wischmeijer A; Angeli E; Gargiulo GD; Picchio FM; Bonvicini M G Ital Cardiol (Rome); 2015 Dec; 16(12):690-5. PubMed ID: 26667946 [TBL] [Abstract][Full Text] [Related]
11. The effect of beta-blocker therapy on progressive aortic dilatation in children and adolescents with Marfan's syndrome: a meta-analysis. Gao L; Mao Q; Wen D; Zhang L; Zhou X; Hui R Acta Paediatr; 2011 Sep; 100(9):e101-5. PubMed ID: 21443687 [TBL] [Abstract][Full Text] [Related]
12. A new on-line method for predicting aortic root dilatation during two-dimensional echocardiography in pediatric patients with Marfan syndrome using the sinus of valsalva to annulus ratio. Mart CR; Khan SA; Smith FC; Kavey RE Pediatr Cardiol; 2003; 24(2):118-21. PubMed ID: 12370793 [TBL] [Abstract][Full Text] [Related]
13. The effects of losartan versus beta-blockers on cardiovascular protection in marfan syndrome: A systematic review and meta-analysis. Kang YN; Chi SC; Wu MH; Chiu HH J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):182-190. PubMed ID: 31003918 [TBL] [Abstract][Full Text] [Related]
14. The natural history of aortic dilatation in Marfan syndrome. Hwa J; Richards JG; Huang H; McKay D; Pressley L; Hughes CF; Jeremy RW Med J Aust; 1993 Apr; 158(8):558-62. PubMed ID: 8487722 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome. Al-Abcha A; Saleh Y; Mujer M; Boumegouas M; Herzallah K; Charles L; Elkhatib L; Abdelkarim O; Kehdi M; Abela GS Am J Cardiol; 2020 Aug; 128():101-106. PubMed ID: 32650901 [TBL] [Abstract][Full Text] [Related]
16. Role of angiotensin receptor blockers for management of aortic root dilation associated with Marfan syndrome. Loomba RS; Arora RR Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1257-9. PubMed ID: 21985537 [No Abstract] [Full Text] [Related]
17. A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome. Thakur V; Rankin KN; Hartling L; Mackie AS Cardiol Young; 2013 Aug; 23(4):568-81. PubMed ID: 23083542 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype. De Backer J Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome. Roman MJ; Rosen SE; Kramer-Fox R; Devereux RB J Am Coll Cardiol; 1993 Nov; 22(5):1470-6. PubMed ID: 8227807 [TBL] [Abstract][Full Text] [Related]
20. Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Nollen GJ; Groenink M; Tijssen JG; Van Der Wall EE; Mulder BJ Eur Heart J; 2004 Jul; 25(13):1146-52. PubMed ID: 15231373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]